In 2023, Dr. Frederic Moll earned $26.85M in total compensation at PROCEPT BioRobotics Corporation, including $612.58K salary, $512.73K bonus and $25.72M in stock. Most recently acquired 1,376 shares in Jun 2024. Currently holds stock worth $32.23M. Led PROCEPT BioRobotics Corporation as CEO for 2 years.
Compensation History
Annual executive compensation data for Dr. Frederic Moll, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$26.85M
Salary
$612.58K
Bonus
$512.73K
Other
$0.00
Salary
$612.58KBoard Justification
The compensation philosophy is to align the interests of executives with stockholder interests, attract and retain talent, and reward performance that contributes to the company's success.
Bonus
$512.73KBoard Justification
Cash bonus payout of 83.7% of target based on performance metrics for the year 2023.
Other Compensation
$0.00Board Justification
No other compensation reported for 2023.
Restricted Stock
Board Justification
RSUs that vested in 2023, with a total of 119,332 shares.
Performance Metrics
Performance metrics included revenue targets, U.S. procedures completed, and adjusted EBITDA.
Dr. Frederic Moll
Founder and Ex-CEO of PROCEPT BioRobotics Corporation
Education
M.D. from Stanford University; B.S. in Biology from the University of California, Berkeley.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
September 1, 1958 - 67 years ago
CEO of PROCEPT BioRobotics Corporation for
2 years 8 months (Oct 2021 - Jul 2024)
Previous Experience
Co-founder and CEO of several medical device companies including Intuitive Surgical and Hansen Medical.
Other PROCEPT BioRobotics Corporation CEOs
Holdings
Track Dr. Frederic Moll's stock holdings and portfolio value over time.
Total Stock Sold
$3.05M
$3.05M
79,000 PRCT shares
What if they kept their stock?
If Dr. Frederic Moll didn't sell their stock, today they would have:
Extra PRCT79,000 shares worth $2.83M.
This is -7.15% and $218.04K less than what they got when they sold the stock.
Insider Trading
Dr. Frederic Moll's recent stock transactions, purchases, and sales filed with the SEC.
1,376 shares
PRCT
Jun 4, 2024
Received
$3.07M
PRCT at $38.87/share
Dec 6, 2023
Sale
2,711 shares
PRCT
Jun 15, 2023
Received
$75.00K
PRCT at $37.48/share
Jun 7, 2022
Received
$10.00M
PRCT at $25.00/share
Sep 17, 2021
Purchase
Rivals
Compare Dr. Frederic Moll with competitor CEOs and industry peers.